Study Suggests Transplant Recipients Are at Greater Risk of Developing RSV

Immunocompromised patients, especially transplant recipients, face heightened RSV risks, leading to severe infections and complications.

NCCN Flash Update: Updated CML Guidelines Emphasize Distress Screening, Drug Interactions, and Cost

The updated version 1.2026 NCCN Guidelines for chronic myeloid leukemia (CML) emphasize individualized treatment strategies, TKI-specific considerations, drug interaction management,…

NCCN Flash Update: Linvoseltamab Added as Preferred Regimen After 4 Prior Therapies for Multiple Myeloma

The National Comprehensive Cancer Network (NCCN) has released multiple myeloma guidelines version 2.2026 to include linvoseltamab as a preferred treatment…

NCCN Flash Update: Ovarian Cancer Guidelines Version 3.2025 Released With Maintenance Therapy Adjustment for HR-Deficiency

The National Comprehensive Cancer Network (NCCN) has updated its ovarian cancer guidelines version 3.2025 to recommend niraparib as maintenance therapy…

Psychiatric Medication Adherence in Patients Experiencing Homelessness

Unique barriers can lead to psychiatric medication adherence rates as low as 26%.

HIV Reporting Meets the Front Line: How Pharmacists Translate Global Health Into Local Care

Pharmacists play a vital role in translating global health news into actionable knowledge for their communities.

Insulin Efsitora Alfa Demonstrates A1C Reduction in Various Clinical Trials

Once-weekly efsitora alfa shows promising hemoglobin A1C reduction in type 2 diabetes (T2D), simplifying insulin therapy and reducing injection frequency…

Study Finds HER2-Negative Outperforms HER2-Low in Neoadjuvant Chemotherapy Response in Breast Cancer

Research reveals HER2-negative breast cancer shows higher pCR rates than HER2-low, influencing neoadjuvant chemotherapy strategies for early-stage patients.

CDC-Led Study Affirms Robust Effectiveness of 2023-2024 COVID-19 Vaccines in Reducing Illness Severity, Mortality

A large retrospective study funded by the CDC indicates broad additional protection against COVID-19, especially for older adults and immunocompromised…